Lupin launches generic Banzel
Generic Banzel is used for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children aged 4 years old and older and adults.
Lupin is introducing Rufinamide Oral Suspension, 40 mg/ml, which is the generic of Eisai’s Banzel Oral Suspension.
Generic Banzel is used for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children aged 4 years old and older and adults.
[Read more: Lupin receives FDA OK for generic Banzel]
Rufinamide Oral Suspension (Banzel) had a market value of roughly $72 million, according to IQVIA April 2023 data.
[Read more: FDA approves 3 Lupin generics]